| Carteolol HCl EP Impurity E |
盐酸卡特洛尔EP杂质E |
56660-90-3 |
| 2-Amino-5-nitroso-4,6-pyrimidinediol |
2-Amino-5-nitroso-4,6-pyrimidinediol |
55482-22-9 |
| 1,3-bis(2-chloroethyl)benzimidazolin-2-one |
氟班色林杂质 |
55470-74-1 |
| Carbamic acid, (2-nitro-3-pyridinyl)-, ethyl ester |
Carbamic acid, (2-nitro-3-pyridinyl)-, ethyl ester |
55304-91-1 |
| Carteolol HCl EP Impurity G |
盐酸卡特洛尔EP杂质G |
54945-72-1 |
| 3(S)-Oxidosqualene |
3(S)-Oxidosqualene |
54910-48-4 |
| 4H-Oxireno[3,4]cyclopenta[1,2-b]furan-4-one, hexahydro-, [1aS-(1aα,2aα,5aα,5bα)]- (9CI) |
前列腺素中间体54483-30-6,54483-30-6 |
54483-30-6 |
| Flunixin Meglumine Impurity 4（Flunixin Meglumine EP Impurity D） |
Flunixin Meglumine Impurity 4（Flunixin Meglumine EP Impurity D） |
54396-42-8 |
| Erlotinib Impurity 81 |
Erlotinib Impurity 81 |
53666-33-4 |
| 5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
| (2Z)-2-benzylidene-1-azabicyclo[2.2.2]octan-3-one |
马罗皮坦杂质1 |
52455-71-7 |
| 2-(1-Naphthyl)propionaldehyde |
2-(1-Naphthyl)propionaldehyde |
52417-52-4 |
| 5-Methyl-2-phenoxypyridine |
吡非尼酮杂质1 |
51933-81-4 |
| (3-HYDROXYPROPYL)TRIPHENYLPHOSPHONIUM BROMIDE |
盐酸奥洛他定杂质14 |
51860-45-8 |
| Otilonium Bromide intermediates |
奥替溴铵中间体 |
51444-79-2 |
| Salbutamol Related Compound 2 |
沙丁胺醇相关化合物2 |
51234-21-0 |
| alpha-hydroxybenzeneacetyl chloride |
Α-羟基苯乙酰氯 |
50916-31-9 |
| BB-K 6 |
BB-K 6 |
50866-72-3 |
| L-Cysteine,S,S'-1,3-propanediylbis- (9CI) |
福多司坦杂质 |
50727-79-2 |
| Ozagrel impurity |
奥扎格雷杂质 |
50363-84-3 |
